Log In
Print this Print this


Also known as: Factor X coagulation product

  Manage Alerts
Collapse Summary General Information
Company Bio Products Laboratory Ltd.
DescriptionPlasma-derived Factor X protein therapy
Molecular Target
Mechanism of ActionEnzyme replacement therapy
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentMarketed
Standard Indication Hematology (unspecified)
Indication DetailsTreat hereditary Factor X deficiency
Regulatory Designation U.S. - Orphan Drug (Treat hereditary Factor X deficiency)

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today